Recurrent vulvar cancer

Clinical Obstetrics and Gynecology

Volumn 48, Issue 4, 2005, Pages 879-883

  Fonseca Moutinho, José Alberto ^a,b  

^a Portuguese Cancer Institute   (Portugal)

^b Centre Médico Serpa Pinto   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER THERAPY; HUMAN; RECURRENT DISEASE; REVIEW; VULVA CANCER;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; NEOPLASM RECURRENCE, LOCAL; VULVAR NEOPLASMS;

EID: 29544452265     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.grf.0000179671.98939.fe     Document Type: Review

References (31)

1. Parkin DM, Muir CS. Cancer Incidence in Five Continents, vol VI. IARC Scientific Publications No 120. Lyon: IARC; 1992.
2. Sturgeon SR, Brinton LA, Devesa SS, et al. In situ and invasive vulvar cancer incidence trends. Am J Obstet Gynecol. 1992;166: 1482-1485.
3. Platz CE, Benda JA. Female genital tract cancer. Cancer. 1995;75:270-294.
4. van der Velden J, van Lindert ACM, Gimbrere CHF, et al. Epidemiologic data on vulvar cancer: comparison of hospital with population based data. Gynecol Oncol. 1996;62:379-383.
5. Cavanagh D. Vulvar cancer. Continuing evolution in management. Gynecol Oncol. 1997;66:362-367.
6. Dhar KK, Woolas RP. Changes in the management of vulval cancer. Best Pract Res Clin Obstet Gynecol. 2003;17:529-542.
7. Patterson F, Creasman WT, Shepherd JH, et al. Annual Report of the Results of Treatment in Gynaecological Cancer, vol 22. Stockholm: International Federation of Gynaecology and Obstetrics; 1995.
8. Stehman FB, Bundy BN, Ball H, et al. Sites of failure and times to failure in the carcinoma of the vulva treated conservatively: a Gynecologic Oncology Group study. Am J Obstet Gynecol. 1996;174:1128-1133.
9. Rhodes CA, Shafi MI. The management of squamous cell vulval cancer: a population based retrospective study of 411 cases. Br J Obstet Gynaecol. 1998;105:200-205.
10. Magrina JF, Gonzalez-Bosquet J, Weaver AL, et al. Primary squamous cell cancer of the vulva: radical versus modified radical vulvar surgery. Gynecol Oncol. 1998;71:116-121.
11. Preti M, Ronco G, Ghiringhello B, et al. Recurrent squamous cell carcinoma of the vulva. Clinicopathologic determinants identifying low risk patients. Cancer. 2000;88:1869-1876.
12. Maggino T, Landoni F, Sartori E, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study. Cancer. 2000;89:116-122.
13. Rodolakis A, Diakomanolis E, Voulgaris Z, et al. Squamous vulvar cancer: a clinically based individualization of treatment. Gynecol Oncol. 2000;78:346-351.
14. de Hullu JA, Hollema H, Lolkema S, et al. Vulvar carcinoma: the price of less radical surgery. Cancer. 2002;95:2331-2338.
15. Fonseca-Moutinho JA, Coelho MC, Silva DP. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en-bloc radical vulvectomy and bilateral groin dissection. J Reprod Med. 2000;45:672-678.
16. Rouzier R, Haddad B, Plantier F, et al. Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet Gynecol. 2002;100:1159-1167.
17. Heaps JM, Fu YS, Montz FJ, et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol. 1990;38:309-314.
18. Cohn DE, Dehdashti F, Gibb RK, et al. Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol. 2002;85:179-184.
19. Salom EM, Penalver M. Recurrent vulvar cancer. Curr Treat Options Oncol. 2002;3:143-153.
20. Hopkins MP, Reid GC, Morley GW. The surgical management of recurrent squamous cell carcinoma of the vulva. Obstet Gynecol. 1990;75:1001-1005.
21. Piura B, Masotina A, Murdoch J, et al. Recurrent squamous cell carcinoma of the vulva: a study of 73 cases. Gynecol Oncol. 1993;48:189-195.
22. Chakolva G, Karagiozov A. The surgical management of recurrent carcinoma of the vulva. Eur J Gynaecol Oncol. 1993;14:318-322.
23. Tilmans AS, Sutton GP, Look KY, et al. Recurrent squamous carcinoma of the vulva. Am J Obstet Gynecol. 1992;167:1383-1389.
24. Angioli R, Estape R, Cantuaria G, et al. Urinary complications of the Miami Pouch: trend of conservative management. Am J Obstet Gynecol. 1998;179:343-348.
25. Hopkins MP, Morley GW. Pelvic exenteration for the treatment of vulvar cancer. Cancer. 1992;70:2835-2838.
26. Miller B, Morris M, Levenback C, et al. Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol Oncol. 1995;58:202-205.
27. Boronow RC, Hickman BT, Reagan MT, et al. Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer. Am J Clin Oncol. 1987;10:171-181.
28. Prempree T, Amornmarn R. Radiation treatment of recurrent carcinoma of the vulva. Cancer. 1984;54:1943-1949.
29. Landoni F, Maneo A, Zanetta G, et al. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol. 1996;61:321-327.
30. Tewari K, Cappuccini F, Syed N, et al. Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancer. Am J Obstet Gynecol. 1999;181:91-98.
31. Hoffman M, Greenberg S, Greenberg H, et al. Interstitial radiotherapy for the treatment of advanced or recurrent vulvar and distal vaginal malignancy. Am J Obstet Gynecol. 1990;162:1278-1282.